Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access


Serum preptin and amylin levels in acne vulgaris patients

Nese Gocer Gurok; Ibrahim Kokcam; Demet Cicek; Suleyman Aydin; Denizmen Aygun.

Acne vulgaris is a common disease with multi-factorial etiology that occupies the pilosebaceous unit. Several recent studies demonstrated that insulin and insulin resistance can play a role in acne pathogenesis. In the present study, the roles of preptin and amylin, which are directly associated with insulin secretion and released from pancreas beta cells, in acne vulgaris pathogenesis were investigated. The study was conducted with 40 cases with acne vulgaris and the control group that included 40 healthy subjects with similar body mass index. Serum preptin and amylin levels and fasting blood glucose, triglyceride, total cholesterol, LDL, VLDL, HDL, C-peptide, insulin and HbA1c levels were examined in the study group. HOMA-IR values were calculated. Although patient group serum preptin and amylin levels were higher when compared to the control group, however the difference was not statistically significant (p> 0.05). It was determined that there was a positive correlation between severity of the disease and amylin levels. In the patient group, it was found that the glucose level was significantly higher when compared to the control group (p 0.05). It is considered that increased preptin and amylin levels in acne vulgaris patients may be associated with the etiopathogenesis of the disease. We also considered that decreasing the elevated levels of these two peptides to normal levels may be helpful for the treatment of the disease.

Key words: Acne vulgaris;insulin resistance;preptin;amylin

Full-text options

Full-text Article

American Journal of Diagnostic Imaging


BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.